GRASTIVA®

TACROLIMUS
GRASTIVA®

Available Presentations:

  • GELATIN CAPSULES, 0.5 mg, No. 50
  • GELATIN CAPSULES, 1 mg, No. 50
  • GELATIN CAPSULES, 5 mg, No. 50
INN: Tacrolimus
ATC Group: L04AD02
Immunosuppressor, calcineurin inhibitor
Indications for Use: Prevention of reaction of rejection of liver, kidney, or heart allograft. Treatment of reaction of rejection of allograft resistant to other immunosuppressive therapy protocols.
Dispensing Rules: on prescription
VED Status: listed in VED List
Marketing Authorization: LP-0033661 of 06 June 2016
Shelf Life: 0.5 mg capsules: 2 years
1 mg and 5 mg capsules: 3 years
Conditions of Storage: store at or below 25°C.


THE INFORMATION ON THIS PAGE IS NOT AN ADVERTISEMENT AND IS INTENDED TO INFORM ON THE PRODUCTS MANUFACTURED BY THE COMPANY.

THE MEDICINAL PRODUCTS HAVE CONTRAINDICATIONS, CONTACT YOUR DOCTOR.